The Altascientist Issue 36: Navigating the Key Considerations of Your Nonclinical Cell and Gene Therapy Studies
Alta Sciences
JANUARY 11, 2024
The in vivo nonclinical study of cell and gene therapies includes a thorough understanding of on-and-off-target activity, immune responses, and other adverse events just to name a few. There are three primary vectors employed in gene therapy: adeno-associated virus (AAV), adenovirus, or lentivirus vectors.
Let's personalize your content